EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Recurrence of Herpetic Keratitis after COVID-19 Vaccination: A Report of Two Cases

Ali Mahdavi Fard, Jeffrey Desilets, Sangita Patel iD

Case Reports in Ophthalmological Medicine · 19.05.2022 · 2022 · 1-3

DOI: 10.1155/2022/7094893 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Ophthalmological Medicine, erschienen am 19.05.2022. Verfasst von Ali Mahdavi Fard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ross Eye Institute, Department of Ophthalmology, Jacobs School of Medicine and Biomedical Sciences, State University at Buffalo, Buffalo, New York, U…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recurrence of herpetic keratitis following vaccination has been documented following vaccination with the Zostavax, trivalent flu, hepatitis A, and rabies vaccines. The USFDA and WHO have acknowledged that the novel COVID-19 vaccines similarly have a risk of reactive immunologic-based inflammation, namely, myositis, pericarditis, and Guillain-Barré syndrome. Case Presentation. We present two patients with latent herpetic keratitis who experienced reactivation of keratitis within weeks of COVID-19 vaccination despite prolonged periods of prior latency. A 52-year-old healthy male with no herpes simplex virus (HSV) keratitis recurrences in two years developed visual decline and patchy stromal haze within 24-48 hours of receiving the second Pfizer-BioNTech (COVID-19 BNT162b2) vaccine. A 67-year-old female with chronic neurotrophic keratitis developed her most severe exacerbation of herpes zoster keratitis in over 10 years occurring 2-3 weeks after her first Moderna (mRNA-1273) vaccine, which was later complicated by bacterial superinfection.

Conclusions

The COVID-19 vaccines work by generating both adaptive humoral and cellular immune responses in humans, including elevation of anti-spike neutralizing antibody titers, antigen-specific CD4+ and CD8+ T-cell responses, and increased levels of proinflammatory cytokines such as interferon gamma (IFNγ). The general activation of the T-cell-mediated immune response and proinflammatory cytokines such as IFNγ may underlie the role of the COVID vaccines in reactivation of herpetic stromal keratitis and the clinical findings in our reported cases.

Autor:innen und Institutionen

  • Ross Eye Institute, Department of Ophthalmology, Jacobs School of Medicine and Biomedical Sciences, State University at Buffalo, Buffalo, New York, USA.
  • Research and Ophthalmology Services, Veterans Administration of Western New York Healthcare System, Buffalo, NY, USA.

ORCID-Profile: Sangita Patel

Zitieren

APA

Fard, A. M., Desilets, J., & Patel, S. (2022). Recurrence of Herpetic Keratitis after COVID-19 Vaccination: A Report of Two Cases. Case Reports in Ophthalmological Medicine, 2022, 1-3. https://doi.org/10.1155/2022/7094893

Vancouver

Fard AM, Desilets J, Patel S. Recurrence of Herpetic Keratitis after COVID-19 Vaccination: A Report of Two Cases. Case Reports in Ophthalmological Medicine. 2022;2022:1-3. doi:10.1155/2022/7094893

BibTeX
@article{Fard2022,
  author = {Fard, Ali Mahdavi and Desilets, Jeffrey and Patel, Sangita},
  title = {Recurrence of Herpetic Keratitis after COVID-19 Vaccination: A Report of Two Cases},
  journal = {Case Reports in Ophthalmological Medicine},
  year = {2022},
  volume = {2022},
  pages = {1--3},
  doi = {10.1155/2022/7094893}
}
Kostenlos starten →